This is the first report describing the mechanism underlying CtBP2 overexpression, identifying the role played by CtBP2 in EMT in HCC and showing CtBP2 is an effective predictive biomarker of patient outcome after HCC surgery. This evidence concerns the gene CTBP2 and hepatocellular carcinoma.